Trial · NCT01622660
Adverse events28
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 28
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Elevated ALT | Hepatobiliary disorders | Gemcitabine and Pazopanib | 1 | 2 | |
| other | Lymphopenia | Blood and lymphatic system disorders | Gemcitabine and Pazopanib | 1 | 2 | |
| other | Elevated Alkaline Phosphatase | Hepatobiliary disorders | Gemcitabine and Pazopanib | 1 | 2 | |
| other | Anemia | Blood and lymphatic system disorders | Gemcitabine and Pazopanib | 1 | 2 | |
| other | Elevated AST | Hepatobiliary disorders | Gemcitabine and Pazopanib | 1 | 2 | |
| other | Blood Bilrubin Increased | Hepatobiliary disorders | Gemcitabine and Pazopanib | 1 | 2 | |
| other | Constipation | Gastrointestinal disorders | Gemcitabine and Pazopanib | 1 | 2 | |
| other | Diarrhea | Gastrointestinal disorders | Gemcitabine and Pazopanib | 1 | 2 | |
| other | Dysgeusia | Nervous system disorders | Gemcitabine and Pazopanib | 1 | 2 | |
| other | Fatigue | General disorders | Gemcitabine and Pazopanib | 2 | 2 | |
| other | Fever | General disorders | Gemcitabine and Pazopanib | 1 | 2 | |
| other | Gastroesophageal reflux disorder | Gastrointestinal disorders | Gemcitabine and Pazopanib | 1 | 2 | |
| other | Gastrointestinal disorders, other | Gastrointestinal disorders | Gemcitabine and Pazopanib | 1 | 2 | |
| other | Headache | Nervous system disorders | Gemcitabine and Pazopanib | 1 | 2 | |
| other | Hiccups | Respiratory, thoracic and mediastinal disorders | Gemcitabine and Pazopanib | 1 | 2 | |
| other | Hypoalbuminemia | Metabolism and nutrition disorders | Gemcitabine and Pazopanib | 1 | 2 | |
| other | Hypocalcemia | Metabolism and nutrition disorders | Gemcitabine and Pazopanib | 1 | 2 | |
| other | Hyponatremia | Metabolism and nutrition disorders | Gemcitabine and Pazopanib | 1 | 2 | |
| other | INR increased | Investigations | Gemcitabine and Pazopanib | 1 | 2 | |
| other | Mucositis oral | Gastrointestinal disorders | Gemcitabine and Pazopanib | 1 | 2 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01622660/events